Mark A. Richardson
13Patents
6h-index
16Co-inventors
59Inventor score
Filing activity: Aug 2, 1982 → Jun 3, 1998
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5098837A | Macrolide biosynthetic genes for use in streptomyces and other organisms | Emerging Cross-Sectional Technologies | 46 | Expired |
| US5190871A | Use of the site-specific integrating function of phage .phi.C31 | Chemistry; Metallurgy | 18 | Expired |
| US4559300A | Method for using an homologous bacillus promoter and associated natural or modified ribosome binding site-containing DNA sequence in streptomyces | Emerging Cross-Sectional Technologies | 15 | Expired |
| US4513086A | Cloning vectors for use in streptomyces and related organisms | Chemistry; Metallurgy | 15 | Expired |
| US5945320A | Platenolide synthase gene | Chemistry; Metallurgy | 10 | Expired |
| US5980938A | Effect of compounds that suppress induction of plasminogen activator inhibitor 1 (PAI-1) | Human Necessities | 6 | Expired |
| US5948795A | Benzothiopene compounds, and uses and formulations thereof | Chemistry; Metallurgy | 5 | Expired |
| US5962698A | Benzothiophene compounds, and uses and formulations thereof | Chemistry; Metallurgy | 5 | Expired |
| US5731328A | Methods of inhibiting plasminogen activator inhibitor 1 | Human Necessities | 3 | Expired |
| US5792798A | Method for inhibiting plasminogen activator inhibitor 1 | Human Necessities | 1 | Expired |
| US4886757A | Spiramycin resistance-conferring cloning vectors | Emerging Cross-Sectional Technologies | 1 | Expired |
| US4752577A | Method for using a novel transcriptional- and translational-activating sequence in streptomyces | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5780648A | Benzothiophene compounds, and uses formulations thereof | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.